Isildinha M. Reis
YOU?
Author Swipe
View article: Sociodemographic disparities among Floridians diagnosed with oropharyngeal cancer
Sociodemographic disparities among Floridians diagnosed with oropharyngeal cancer Open
Distant stage at OPC diagnosis is influenced by many risk factors, including race, sex, age, marital, and insurance status. Geographical mapping analysis can help direct screening efforts to high-risk communities.
View article: Extracorporeal Photopheresis for Chronic Graft‐Versus‐Host Disease According to 2014 <scp>NIH</scp> Consensus Criteria
Extracorporeal Photopheresis for Chronic Graft‐Versus‐Host Disease According to 2014 <span>NIH</span> Consensus Criteria Open
Chronic graft‐versus‐host disease (cGVHD) remains a major cause of morbidity and mortality following allogeneic hematopoietic stem cell transplantation. Many cGVHD patients require prolonged systemic immunosuppression with corticosteroids,…
View article: Differences in breast cancer outcomes amongst Caribbean born women in Florida, USA—a population-based analysis
Differences in breast cancer outcomes amongst Caribbean born women in Florida, USA—a population-based analysis Open
Jovanka Ravix reported receiving grants from the National Institutes of HealthNIMHDF31MD020275. Sophia George was funded by the National Institute on Minority Health and Health Disparities (L60MD014321), Chan Zuckerberg Initiative - Ancest…
View article: <scp>PET</scp>/<scp>CT</scp> in the Staging and Treatment Response Assessment of Patients With Extranodal Marginal Zone Lymphoma
<span>PET</span>/<span>CT</span> in the Staging and Treatment Response Assessment of Patients With Extranodal Marginal Zone Lymphoma Open
18 Fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) is the standard imaging modality in lymphoma. The 2014 Lugano classification considers extranodal marginal zone lymphoma (EMZL) a non‐FDG‐avid disease, r…
View article: Socioeconomic disparities: a more important risk factor for advanced-stage oral cancer in Florida than smoking?
Socioeconomic disparities: a more important risk factor for advanced-stage oral cancer in Florida than smoking? Open
Purpose To explore the associations between sociodemographic factors with advanced-stage oral cavity cancer (OCC) presentation among Floridians. Methods Demographic and cancer data on OCC patients ( n = 7,826) diagnosed between 2010 and 20…
View article: Metabolomic Profiling of Disease Progression Following Radiotherapy for Breast Cancer
Metabolomic Profiling of Disease Progression Following Radiotherapy for Breast Cancer Open
Background: This study aims to explore metabolic biomarkers and pathways in breast cancer prognosis. Methods: We performed a global post-radiotherapy (RT) urinary metabolomic analysis of 120 breast cancer patients: 60 progression-free (PF)…
View article: Outcomes of follicular lymphoma with leukemic phase in the modern era: results from a large multicenter study
Outcomes of follicular lymphoma with leukemic phase in the modern era: results from a large multicenter study Open
[Figure: see text]
View article: Supplementary Table S3 from Hepatocellular Carcinoma Etiology Drives Survival Outcomes: A Population-Based Analysis
Supplementary Table S3 from Hepatocellular Carcinoma Etiology Drives Survival Outcomes: A Population-Based Analysis Open
3. Supplementary Table S3 shows a multivariable Cox proportional hazards regression model in which HCC-specific survival is assessed based on cigarette smoking status, with the reference population of past smokers.
View article: Data from Hepatocellular Carcinoma Etiology Drives Survival Outcomes: A Population-Based Analysis
Data from Hepatocellular Carcinoma Etiology Drives Survival Outcomes: A Population-Based Analysis Open
Background:Previous survival studies on hepatocellular carcinoma (HCC) by etiology are limited to hospital-based series, restricted cohorts, and monolithic etiologic categories. We studied population-based survival by seven mutually exclus…
View article: Supplementary Table S4 from Hepatocellular Carcinoma Etiology Drives Survival Outcomes: A Population-Based Analysis
Supplementary Table S4 from Hepatocellular Carcinoma Etiology Drives Survival Outcomes: A Population-Based Analysis Open
4. Supplementary Table S4 shows multivariable Cox proportional hazards regression models in which HCC-specific survival is assessed based on period of diagnosis, prior or during 2013 and after 2013, for HCV only cases and for non-HCV relat…
View article: Supplementary Table S1 from Hepatocellular Carcinoma Etiology Drives Survival Outcomes: A Population-Based Analysis
Supplementary Table S1 from Hepatocellular Carcinoma Etiology Drives Survival Outcomes: A Population-Based Analysis Open
1. Supplementary Table S1 shows International Classification of Diseases discharge codes used to define the following hepatocellular carcinoma etiologies: chronic hepatitis C virus infection, chronic hepatitis B virus infection, alcohol-re…
View article: Supplementary Table S5 from Hepatocellular Carcinoma Etiology Drives Survival Outcomes: A Population-Based Analysis
Supplementary Table S5 from Hepatocellular Carcinoma Etiology Drives Survival Outcomes: A Population-Based Analysis Open
5. Supplementary Table S5 shows age-adjusted 5-year HCC-specific survival by single etiology or select dual etiology groups, a sensitivity analysis for all HCC cases and for complete HCC cases.
View article: Supplementary Table S2 from Hepatocellular Carcinoma Etiology Drives Survival Outcomes: A Population-Based Analysis
Supplementary Table S2 from Hepatocellular Carcinoma Etiology Drives Survival Outcomes: A Population-Based Analysis Open
2. Supplementary Table S2 shows International Classification of Diseases discharge codes used to define cirrhosis and ascites.
View article: Supplementary Table S6 from Hepatocellular Carcinoma Etiology Drives Survival Outcomes: A Population-Based Analysis
Supplementary Table S6 from Hepatocellular Carcinoma Etiology Drives Survival Outcomes: A Population-Based Analysis Open
6. Supplementary Table S6 shows age-adjusted Cox proportional hazards regression models in which HCC-specific survival is assessed by etiology for HCC cases with complete variables.
View article: Loncastuximab Tesirine with Rituximab Induces Robust and Durable Complete Metabolic Responses in High-Risk Relapsed/Refractory Follicular Lymphoma
Loncastuximab Tesirine with Rituximab Induces Robust and Durable Complete Metabolic Responses in High-Risk Relapsed/Refractory Follicular Lymphoma Open
Introduction: A paucity of data exists about loncastuximab tesirine (loncastuximab) activity in follicular lymphoma (FL). Fourteen patients with relapsed/refractory (r/r) FL were enrolled in the original phase I study, demonstrating an ove…
View article: Reproductive Risk Factor Patterns in Caribbean Women With Breast Cancer Across 4 Generations
Reproductive Risk Factor Patterns in Caribbean Women With Breast Cancer Across 4 Generations Open
Importance Breast cancer (BC) is commonly diagnosed among Caribbean women. Shifts in reproductive patterns modify the incidence of BC diagnosis and age at BC diagnosis in population-based studies; however, reproductive patterns in Caribbea…
View article: Hepatocellular Carcinoma Etiology Drives Survival Outcomes: A Population-Based Analysis
Hepatocellular Carcinoma Etiology Drives Survival Outcomes: A Population-Based Analysis Open
Background: Previous survival studies on hepatocellular carcinoma (HCC) by etiology are limited to hospital-based series, restricted cohorts, and monolithic etiologic categories. We studied population-based survival by seven mutually exclu…
View article: Soluble CD44 in oral rinses for the early detection of cancer: a prospective cohort study in high-risk individuals
Soluble CD44 in oral rinses for the early detection of cancer: a prospective cohort study in high-risk individuals Open
Background There are 54,000 new cases of oral cavity and oropharyngeal cancer in the United States and more than 476,000 worldwide each year. Oral cavity and oropharyngeal squamous cell carcinoma make up most tumors with five-year survival…
View article: Risk of transformation by frontline management in follicular and marginal zone lymphomas: a US population–based analysis
Risk of transformation by frontline management in follicular and marginal zone lymphomas: a US population–based analysis Open
Follicular lymphoma (FL) and marginal zone lymphoma (MZL) often have long overall survival (OS), however, high-grade transformation (HGT) to diffuse large B-cell lymphoma markedly reduces survival. The roles of upfront treatment vs observa…
View article: Metabolomics in Radiotherapy-Induced Early Adverse Skin Reactions of Breast Cancer Patients
Metabolomics in Radiotherapy-Induced Early Adverse Skin Reactions of Breast Cancer Patients Open
Our data show that the alanine, aspartate, and glutamate metabolism pathways had the highest impact value on RT-induced EASRs. Future larger studies are warranted to validate our findings and facilitate targeted interventions for preventin…
View article: (107) A PHASE 2 RANDOMIZED, PLACEBO-CONTROLLED CROSSOVER TRIAL TO EVALUATE SAFETY AND EFFICACY OF PLATELET-RICH PLASMA INJECTIONS FOR PEYRONIE’S DISEASE: CLINICAL TRIAL UPDATE
(107) A PHASE 2 RANDOMIZED, PLACEBO-CONTROLLED CROSSOVER TRIAL TO EVALUATE SAFETY AND EFFICACY OF PLATELET-RICH PLASMA INJECTIONS FOR PEYRONIE’S DISEASE: CLINICAL TRIAL UPDATE Open
Introduction Peyronie’s Disease (PD) is a medical condition characterized by localized inflammation in the penile tunica albuginea, leading to the formation of fibrotic plaques. These plaques cause penile curvature and painful erections, s…
View article: P8. Comparative Outcomes of Proton versus Photon Post-Mastectomy Radiation Therapy in Pre-pectoral Implant Based Breast Reconstruction
P8. Comparative Outcomes of Proton versus Photon Post-Mastectomy Radiation Therapy in Pre-pectoral Implant Based Breast Reconstruction Open
PURPOSE: The rising popularity of Pre-Pectoral Implant-Based Breast Reconstruction (PP-IBBR) and proton radiation lacks outcomes data. We aim to compare complications in PP-IBBR with proton versus photon Post-Mastectomy Radiation Therapy (…
View article: Optimal Management for Primary High Grade Ta Bladder Cancer: Role of re‐staging TURBT and Intravesical Adjuvant Therapy
Optimal Management for Primary High Grade Ta Bladder Cancer: Role of re‐staging TURBT and Intravesical Adjuvant Therapy Open
Objective This study aims to investigate the impact of risk group classification, restaging transurethral resection (re‐TURBT), and adjuvant treatment intensity on recurrence and progression risks in high‐grade Ta tumours in patients with …
View article: Supplementary Table S3 from PET/CT Biomarkers Enable Risk Stratification of Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma Enrolled in the LOTIS-2 Clinical Trial
Supplementary Table S3 from PET/CT Biomarkers Enable Risk Stratification of Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma Enrolled in the LOTIS-2 Clinical Trial Open
Baseline PET/CT metrics (N=138).
View article: Data from PET/CT Biomarkers Enable Risk Stratification of Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma Enrolled in the LOTIS-2 Clinical Trial
Data from PET/CT Biomarkers Enable Risk Stratification of Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma Enrolled in the LOTIS-2 Clinical Trial Open
Purpose:Significant progress has occurred in developing quantitative PET/CT biomarkers in diffuse large B-cell lymphoma (DLBCL). Total metabolic tumor volume (MTV) is the most extensively studied, enabling assessment of FDG-avid tumor burd…
View article: Supplementary Figure S3 from PET/CT Biomarkers Enable Risk Stratification of Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma Enrolled in the LOTIS-2 Clinical Trial
Supplementary Figure S3 from PET/CT Biomarkers Enable Risk Stratification of Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma Enrolled in the LOTIS-2 Clinical Trial Open
Kaplan-Meier curves for progression-free survival and overall survival by loncastuximab tesirine response.
View article: Data from PET/CT Biomarkers Enable Risk Stratification of Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma Enrolled in the LOTIS-2 Clinical Trial
Data from PET/CT Biomarkers Enable Risk Stratification of Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma Enrolled in the LOTIS-2 Clinical Trial Open
Purpose:Significant progress has occurred in developing quantitative PET/CT biomarkers in diffuse large B-cell lymphoma (DLBCL). Total metabolic tumor volume (MTV) is the most extensively studied, enabling assessment of FDG-avid tumor burd…